Sign up for free insights newsletter
AL

Alfresa Holdings Corp Tokyo ADR

ALFRYUnited States

Need professional-grade analysis? Visit stockanalysis.com

$16.23
-0.98%
End of day
Market Cap

$2.98B

P/E Ratio

19.28

Employees

12,452

Dividend Yield

1.33%

Price Chart

Risk-Adjusted Performance

Ratio1W1M3M6M1Y5YScore
Sortino-2.4015.180.160.88-0.252.34
Calmar0.261.01-0.130.39
Sharpe-2.341.820.110.56-0.210.16
Omega0.168.411.261.760.902.31
Martin-39.310.734.09-0.17-3.50
Ulcer0.240.137.975.5433.8612.09

Alfresa Holdings Corp Tokyo ADR (ALFRY) Price Performance

Alfresa Holdings Corp Tokyo ADR (ALFRY) trades on United States in USD. The company is classified in the Healthcare sector under the Medical Distribution industry. The stock currently trades at $16.23, down 0.98% from the previous close.

Over the past year, ALFRY has traded between a low of $12.42 and a high of $16.39. The stock has gained 22.7% over this period. It is currently 30.6% above its 52-week low.

Alfresa Holdings Corp Tokyo ADR has a market capitalization of $2.98B, with a price-to-earnings ratio of 19.28 and a dividend yield of 1.33%.

About Alfresa Holdings Corp Tokyo ADR

Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. It is also involved in the operation of dispensing pharmacies and conducting related businesses; ethical pharmaceuticals wholesaling business; self-medication products wholesaling business; and other medical-related businesses. In addition, the company manufactures and markets active pharmaceutical ingredients; contract distribution services in hospitals; operation, maintenance, and development of information system; supply of cell raw materials; manufacturing of specific processed cells and regenerative medicine products. The company was incorporated in 2003 and is based in Tokyo, Japan.

Company Info

Exchange
United States
Currency
USD

Financial Metrics

Revenue (TTM)
$3.06T
EBITDA
$52.65B
Profit Margin
1.10%
EPS (TTM)
0.85
Book Value
17.10

Technical Indicators

52 Week High
$16.39
52 Week Low
$12.42
50 Day MA
$15.73
200 Day MA
$15.53
Beta
-0.27

Valuation

Trailing P/E
19.28
Forward P/E
N/A
Price/Sales
0.00
Price/Book
0.95
Enterprise Value
$1.51B